Sophrosyne Pharmaceuticals is committed to developing novel therapies to treat alcohol use disorder.
At this time, Sophrosyne is not offering its investigational products through an Expanded Access program. We believe that participation in clinical trials is the most appropriate way to access our investigational products. Our priority is to develop safe and effective therapies and make them available as quickly as possible.
If you are a health care provider interested in learning more about our programs and investigational therapies, please submit a request through our “contact us” link https://www.sophrosynepharma.com/contact-us and we will get back to you as quickly as possible.
